Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 5/20 | 0.86 |
| ▸ | TUBB | P07437 | 5/20 | 0.86 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.86 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.86 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.86 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.86 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.86 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.86 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.86 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.86 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.86 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.86 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.86 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.86 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.86 |
| ▸ | XDH | P47989 | 2/20 | 0.86 |
| ▸ | MAPT | P10636 | 1/20 | 0.86 |
| ▸ | PKM | P14618 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Santin SCHEMBL82415 | 0.92 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL9665640 | 0.90 | MAOA (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1683355 | 0.89 | TUBB4A (0.76) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29598018 | 0.89 | TUBB4A (0.76) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL27685663 | 0.88 | ABCB1 (0.73) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL5073336 | 0.86 | ABCG2 (0.84) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL4649968 | 0.86 | CYP3A4 (0.88) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30131217 | 0.86 | CYP3A4 (0.88) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL31142481 | 0.85 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Betuletol SCHEMBL29400938 | 0.85 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | claimed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | claimed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | claimed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2026-03-31 | — | — | US | disclosed |
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | disclosed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | disclosed |
| CN-109890376-A | Composition is used in PGC-1 α activation | 三得利控股株式会社 | 2019-06-14 | — | — | CN | disclosed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | disclosed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | ITGA8, ITGAL, ITGB2 | TUBB4A 2275/4885TUBB 1328/4885TUBA3C 1261/4885 |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | ITGA8, ICAM1, ITGA2 | TUBB4A 2678/4885TUBB 2216/4885TUBA3C 1287/4885 |
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | TUBB4A 3536/4885TUBB 2804/4885TUBA3C 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.